{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:13:36Z","timestamp":1790878416952,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["KWF NKI 2021-15093"],"award-info":[{"award-number":["KWF NKI 2021-15093"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["NKI 2014-7167"],"award-info":[{"award-number":["NKI 2014-7167"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013421","name":"Pink Ribbon Foundation","doi-asserted-by":"publisher","award":["2014-183 WO 54 PR130027"],"award-info":[{"award-number":["2014-183 WO 54 PR130027"]}],"id":[{"id":"10.13039\/100013421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejca.2023.113276","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T23:43:52Z","timestamp":1691106232000},"page":"113276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Active surveillance versus treatment in low-risk DCIS: Women\u2019s preferences in the LORD-trial"],"prefix":"10.1016","volume":"192","author":[{"given":"Ren\u00e9e S.J.M.","family":"Schmitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen G.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda A.","family":"Gerritsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine M.T.","family":"Sondermeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Verschuur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Houtzager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie","family":"Griffioen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valesca","family":"Ret\u00e8l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Bijker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritse M.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederieke","family":"van Duijnhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline M.A.","family":"Bleiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejca.2023.113276_bib1","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/cncr.21069","article-title":"The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up","volume":"103","author":"Sanders","year":"2005","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2023.113276_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in situ: to treat or not to treat, that is the question","volume":"121","author":"van Seijen","year":"2019","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2023.113276_bib3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ije\/27.5.735","article-title":"Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening","volume":"27","author":"Shapiro","year":"1998","journal-title":"Int J Epidemiol"},{"issue":"16","key":"10.1016\/j.ejca.2023.113276_bib4","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1016\/j.ejca.2013.06.020","article-title":"Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens","volume":"49","author":"van Luijt","year":"2013","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2023.113276_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1148\/radiol.2512081235","article-title":"Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data","volume":"251","author":"Vinnicombe","year":"2009","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejca.2023.113276_bib6","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2023.113276_bib7","unstructured":"National Comprehensive Cancer Network. DCIS Breast Cancer (version 2020). \u3008https:\/\/www.nccn.org\/patients\/guidelines\/content\/PDF\/stage_0_breast-patient.pdf\u3009."},{"issue":"5","key":"10.1016\/j.ejca.2023.113276_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv372","article-title":"Outcomes of active surveillance for ductal carcinoma in situ: a computational risk analysis","volume":"108","author":"Ryser","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.ejca.2023.113276_bib9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/jnci\/djy220","article-title":"Cancer outcomes in DCIS patients without locoregional treatment","volume":"111","author":"Ryser","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ejca.2023.113276_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-005-9101-z","article-title":"The natural history of ductal carcinoma in situ of the breast: a review","volume":"97","author":"Erbas","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"21","key":"10.1016\/j.ejca.2023.113276_bib11","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast-cancer incidence","volume":"367","author":"Bleyer","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejca.2023.113276_bib12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/M13-2548","article-title":"Prioritization of research addressing management strategies for ductal carcinoma in situ","volume":"160","author":"Gierisch","year":"2014","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ejca.2023.113276_bib13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1158\/1055-9965.EPI-18-0976","article-title":"Predictors of an invasive breast cancer recurrence after DCIS: a systematic review and meta-analyses","volume":"28","author":"Visser","year":"2019","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"10.1016\/j.ejca.2023.113276_bib14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10549-020-05816-x","article-title":"Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study","volume":"183","author":"Groen","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ejca.2023.113276_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jso.23657","article-title":"Breast conserving therapy for DCIS--does size matter?","volume":"110","author":"Kantor","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2023.113276_bib16","unstructured":"Grand Challenge PRECISION consortium website. 1st\u00a0December\u00a02022. \u3008https:\/\/www.dcisprecision.org\/\u3009."},{"issue":"12","key":"10.1016\/j.ejca.2023.113276_bib17","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - the LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.113276_bib18","unstructured":"ClinicalTrials.gov. Identifier NCT02492607: Management of Low-risk (Grade I and II) DCIS (LORD). \u3008https:\/\/clinicaltrials.gov\/show\/NCT02492607\u3009. [Accessed 13th April\u00a02023]."},{"issue":"13","key":"10.1016\/j.ejca.2023.113276_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133259","article-title":"Prediction models and decision aids for women with ductal carcinoma in situ: a systematic literature review","volume":"14","author":"Schmitz","year":"2022","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.ejca.2023.113276_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13163962","article-title":"Preferences of treatment strategies among women with low-risk DCIS and oncologists","volume":"13","author":"Byng","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2023.113276_bib21","unstructured":"Commission E. Eurydice National Education Systems. Updated 30th June 2023. \u3008https:\/\/eurydice.eacea.ec.europa.eu\/national-education-systems\/netherlands\/overview\u3009. [Accessed 13th July 2023]."},{"issue":"8","key":"10.1016\/j.ejca.2023.113276_bib22","first-page":"1787","article-title":"Assessing cancer patients' trust in their oncologist: development and validation of the Trust in Oncologist Scale (TiOS)","volume":"20","author":"Hillen","year":"2012","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2023.113276_bib23","first-page":"855","article-title":"Development and validation of an abbreviated version of the Trust in Oncologist Scale-the Trust in Oncologist Scale-short form (TiOS-SF)","volume":"25","author":"Hillen","year":"2017","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2023.113276_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.janxdis.2006.03.014","article-title":"Fearing the unknown: a short version of the intolerance of uncertainty scale","volume":"21","author":"Carleton","year":"2007","journal-title":"J Anxiety Disord"},{"issue":"1","key":"10.1016\/j.ejca.2023.113276_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jbtep.2012.07.004","article-title":"Confirmatory factor analysis of the Dutch intolerance of uncertainty scale: comparison of the full and short version","volume":"44","author":"Helsen","year":"2013","journal-title":"J Behav Ther Exp Psychiatry"},{"issue":"6","key":"10.1016\/j.ejca.2023.113276_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"10.1016\/j.ejca.2023.113276_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/his.14091","article-title":"The 2019 World Health Organization classification of tumours of the breast","volume":"77","author":"Tan","year":"2020","journal-title":"Histopathology"},{"issue":"16","key":"10.1016\/j.ejca.2023.113276_bib28","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","article-title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","volume":"51","author":"Francis","year":"2015","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.ejca.2023.113276_bib29","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S1470-2045(12)70503-X","article-title":"Time for a low-risk DCIS trial: harnessing public and patient involvement","volume":"13","author":"Fallowfield","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2023.113276_bib30","doi-asserted-by":"crossref","first-page":"k499","DOI":"10.1136\/bmj.k499","article-title":"Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis","volume":"360","author":"Tainio","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ejca.2023.113276_bib31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/1471-0528.16081","article-title":"Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study","volume":"127","author":"Skorstengaard","year":"2020","journal-title":"BJOG"},{"issue":"5\u20136","key":"10.1016\/j.ejca.2023.113276_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5489\/cuaj.2806","article-title":"Active surveillance for the management of localized prostate cancer: guideline recommendations","volume":"9","author":"Morash","year":"2015","journal-title":"Can Urol Assoc J"},{"issue":"6","key":"10.1016\/j.ejca.2023.113276_bib33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.euo.2022.07.004","article-title":"Active surveillance for intermediate-risk prostate cancer: a systematic review, meta-analysis, and metaregression","volume":"5","author":"Baboudjian","year":"2022","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2023.113276_bib34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/ajo.13440","article-title":"Understanding women's choices for management of cervical intraepithelial neoplasia 2 (CIN2): qualitative analysis of a randomised experimental study","volume":"62","author":"Keers","year":"2022","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"8","key":"10.1016\/j.ejca.2023.113276_bib35","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1158\/1055-9965.EPI-15-1079","article-title":"Treatment preferences for active surveillance versus active treatment among men with low-risk prostate cancer","volume":"25","author":"Taylor","year":"2016","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.ejca.2023.113276_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.urology.2021.04.020","article-title":"Patient preferences and treatment decisions for prostate cancer: results from a statewide urological quality improvement collaborative","volume":"155","author":"Paudel","year":"2021","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ejca.2023.113276_bib37","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/pon.5832","article-title":"Patient reported factors influencing the decision-making process of men with localised prostate cancer when considering Active Surveillance-A\u00a0systematic review and thematic synthesis","volume":"31","author":"Cunningham","year":"2022","journal-title":"Psychooncology"},{"issue":"9","key":"10.1016\/j.ejca.2023.113276_bib38","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/cncr.21822","article-title":"Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer","volume":"106","author":"Zeliadt","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2023.113276_bib39","article-title":"Non-surgical treatment for ductal carcinoma in situ of the breasts - a prospective study on patient's perspective","volume":"26","author":"Co","year":"2021","journal-title":"Cancer Treat Res Commun"},{"issue":"12","key":"10.1016\/j.ejca.2023.113276_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004115","article-title":"Factors influencing trust in doctors: a community segmentation strategy for quality improvement in healthcare","volume":"3","author":"Gopichandran","year":"2013","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ejca.2023.113276_bib41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/08968608211027019","article-title":"The use of implicit persuasion in decision-making about treatment for end-stage kidney disease","volume":"42","author":"van Dulmen","year":"2022","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ejca.2023.113276_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejca.2016.07.011","article-title":"Use of implicit persuasion in decision making about adjuvant cancer treatment: a potential barrier to shared decision making","volume":"66","author":"Engelhardt","year":"2016","journal-title":"Eur J Cancer"},{"issue":"19","key":"10.1016\/j.ejca.2023.113276_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194545","article-title":"De-escalating the management of in situ and invasive breast cancer","volume":"14","author":"Angarita","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ejca.2023.113276_bib44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7326\/M21-3577","article-title":"Estimation of breast cancer overdiagnosis in a U.S. breast screening cohort","volume":"175","author":"Ryser","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejca.2023.113276_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2023.02.030","article-title":"Shifting paradigms for the treatment of ductal carcinoma in situ: less is more","author":"Sauder","year":"2023","journal-title":"Surgery"},{"key":"10.1016\/j.ejca.2023.113276_bib46","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1245\/s10434-023-13370-1","article-title":"The landmark series-ductal carcinoma in situ: the evolution of treatment","volume":"30","author":"Nash","year":"2023","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923003787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923003787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:42:05Z","timestamp":1760733725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804923003787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":46,"alternative-id":["S0959804923003787"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2023.113276","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active surveillance versus treatment in low-risk DCIS: Women\u2019s preferences in the LORD-trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2023.113276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"113276"}}